Skip to main content
SpringerLink
Log in
Book cover

Diagnosis and Management of Breast Tumors pp 113–147Cite as

Overview of Radiation Oncology Evaluation and Management of Breast Tumors

  • Chapter
  • First Online:

Abstract

Radiation therapy is indicated as part of the standard of care treatment for the majority of patients with breast cancer. Large clinical trials evaluating the efficacy of radiation treatment for breast cancer date back more than a half century. This chapter discusses the indications for adjuvant radiation therapy for ductal carcinoma in situ and invasive breast cancer. It explores the data supporting the indications for radiation therapy and the benefit of radiation therapy in various clinical settings. Also discussed are the role of regional nodal irradiation, the indications for shorter radiation treatment schedules, and the benefit of a radiation boost. This chapter further addresses the role of partial breast irradiation, and lastly, it discusses the clinical scenarios where omission of radiation may be considered. The role of radiation in treating breast angiosarcomas and malignant phyllodes tumors is not addressed here because these topics are more appropriately discussed in the context of the management of sarcomas.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Polgar C, Fodor J, Major T, Sulyok Z, Kasler M. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013;108(2):197–202. doi:10.1016/j.radonc.2013.05.008.

    Article  PubMed  Google Scholar 

  2. Shah C, Vicini F, Wazer DE, Arthur D, Patel RR. The American Brachytherapy Society consensus statement for accelerated partial breast irradiation. Brachytherapy. 2013;12(4):267–77. doi:10.1016/j.brachy.2013.02.001.

    Article  PubMed  Google Scholar 

  3. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009;209(2):269–77. doi:10.1016/j.jamcollsurg.2009.02.066.

    Article  PubMed  Google Scholar 

  4. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol. 2001;28(4):400–18. doi:S0093775401001531 [pii].

    Article  CAS  PubMed  Google Scholar 

  5. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478–88. doi:10.1093/jnci/djr027.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Donker M, Litiere S, Werutsky G, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol. 2013;31(32):4054–9. doi:10.1200/JCO.2013.49.5077.

    Article  PubMed  Google Scholar 

  7. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol. 2006;45(5):536–43. doi:T673T26276376P0U [pii].

    Article  PubMed  Google Scholar 

  8. Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol. 2011;12(1):21–9. doi:10.1016/S1470-2045(10)70266-7.

    Article  CAS  PubMed  Google Scholar 

  9. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Correa C, McGale P, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162–77. doi:10.1093/jncimonographs/lgq039.

    Article  Google Scholar 

  10. Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev. 2013;11:CD000563. doi:10.1002/14651858.CD000563.pub7.

    Google Scholar 

  11. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77(11):2267–74. doi:10.1002/(SICI)1097-0142(19960601)77:113.0.CO;2-V [pii].

    Article  CAS  PubMed  Google Scholar 

  12. Silverstein MJ, Lagios MD. Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index. Breast J. 2015;21(2):127–32. doi:10.1111/tbj.12368.

    Article  PubMed  Google Scholar 

  13. Wong JS, Chen YH, Gadd MA, et al. Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat. 2014;143(2):343–50. doi:10.1007/s10549-013-2813-6.

    Article  PubMed  Google Scholar 

  14. McCormick B, Winter K, Hudis C, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33(7):709–15. doi:10.1200/JCO.2014.57.9029.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Solin LJ, Gray R, Hughes LL, et al. Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015;33(33):3938–44. doi:10.1200/JCO.2015.60.8588.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32. doi:10.1056/NEJMoa020989.

    Article  PubMed  Google Scholar 

  17. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41. doi:10.1056/NEJMoa022152.

    Article  PubMed  Google Scholar 

  18. Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9. doi:10.1016/S1470-2045(12)70042-6.

    Article  PubMed  Google Scholar 

  19. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14(5):1558–64. doi:10.1200/jco.1996.14.5.1558.

    Article  CAS  PubMed  Google Scholar 

  20. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989;14(3):177–84.

    Article  CAS  PubMed  Google Scholar 

  21. Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst. 1994;86(9):717–22.

    Article  CAS  PubMed  Google Scholar 

  22. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20(20):4141–9. doi:10.1200/JCO.2002.11.101.

    Article  CAS  PubMed  Google Scholar 

  23. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12(7):997–1003.

    Article  CAS  PubMed  Google Scholar 

  24. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087–106. doi:S0140-6736(05)67887-7 [pii].

    Article  CAS  PubMed  Google Scholar 

  25. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16. doi:10.1016/S0140-6736(11)61629-2.

    Article  Google Scholar 

  26. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382–7. doi:10.1200/JCO.2012.45.2615.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):963–70. doi:10.1056/NEJMoa040595.

    Article  CAS  PubMed  Google Scholar 

  28. Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM, PRIME II Investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266–73. doi:10.1016/S1470-2045(14)71221-5.

    Article  PubMed  Google Scholar 

  29. Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307–16. doi:10.1056/NEJMoa1415340.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317–27. doi:10.1056/NEJMoa1415369.

    Article  CAS  PubMed  Google Scholar 

  31. Bartelink H, Maingon P, Poortmans P, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol. 2015;16(1):47–56. doi:10.1016/S1470-2045(14)71156-8.

    Article  PubMed  Google Scholar 

  32. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol. 1997;15(3):963–8. doi:10.1200/jco.1997.15.3.963.

    Article  CAS  PubMed  Google Scholar 

  33. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086–94. doi:10.1016/S1470-2045(13)70386-3.

    Article  PubMed  Google Scholar 

  34. Smith BD, Bentzen SM, Correa CR, et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;81(1):59–68. doi:10.1016/j.ijrobp.2010.04.042.

    Article  PubMed  Google Scholar 

  35. Hahn C, Kavanagh B, Bhatnagar A, et al. Choosing wisely: the American Society for Radiation Oncology’s top 5 list. Pract Radiat Oncol. 2014;4(6):349–55. doi:10.1016/j.prro.2014.06.003.

    Article  PubMed  Google Scholar 

  36. Arthur DW, Vicini FA. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23(8):1726–35. doi:23/8/1726 [pii].

    Article  PubMed  Google Scholar 

  37. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991;338(8763):327–31. doi:0140-6736(91)90475-5 [pii].

    Article  CAS  PubMed  Google Scholar 

  38. Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989;63(10):1912–7.

    Article  CAS  PubMed  Google Scholar 

  39. Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer. Acta Oncol. 1999;38(Suppl 13):9–17.

    Article  PubMed  Google Scholar 

  40. Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N. Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2005;61(5):1328–36. doi:S0360-3016(04)02276-X [pii].

    Article  PubMed  Google Scholar 

  41. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92(3):269–71.

    Article  CAS  PubMed  Google Scholar 

  42. Kuske RR Jr. Breast brachytherapy. Hematol Oncol Clin North Am. 1999;13(3):543–58, vi–vii.

    Article  PubMed  Google Scholar 

  43. Vicini FA, Arthur DW. Breast brachytherapy: North American experience. Semin Radiat Oncol. 2005;15(2):108–15. doi:S1053429604001390 [pii].

    Article  PubMed  Google Scholar 

  44. Chen PY, Vicini FA, Benitez P, et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer. 2006;106(5):991–9. doi:10.1002/cncr.21681.

    Article  PubMed  Google Scholar 

  45. Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol. 2011;100(2):210–4. doi:10.1016/j.radonc.2011.03.011.

    Article  PubMed  Google Scholar 

  46. Arthur DW, Winter K, Kuske RR, et al. A phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008;72(2):467–73. doi:10.1016/j.ijrobp.2007.12.056.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;387(10015):229–38. doi:10.1016/S0140-6736(15)00471-7.

    Article  PubMed  Google Scholar 

  48. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55(2):302–11. doi:S0360301602038117 [pii].

    Article  PubMed  Google Scholar 

  49. Shah C, Wilkinson JB, Lanni T, et al. Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Clin Breast Cancer. 2013;13(3):206–11. doi:10.1016/j.clbc.2012.09.020.

    Article  PubMed  Google Scholar 

  50. Hepel JT, Tokita M, MacAusland SG, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75(5):1290–6. doi:10.1016/j.ijrobp.2009.01.009.

    Article  PubMed  Google Scholar 

  51. Liss AL, Ben-David MA, Jagsi R, et al. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial. Int J Radiat Oncol Biol Phys. 2014;89(1):96–102. doi:10.1016/j.ijrobp.2014.01.005.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Olivotto IA, Whelan TJ, Parpia S, et al. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol. 2013;31(32):4038–45. doi:10.1200/JCO.2013.50.5511.

    Article  PubMed  Google Scholar 

  53. Lei RY, Leonard CE, Howell KT, et al. Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat. 2013;140(1):119–33. doi:10.1007/s10549-013-2623-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Livi L, Meattini I, Marrazzo L, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51(4):451–63. doi:10.1016/j.ejca.2014.12.013.

    Article  PubMed  Google Scholar 

  55. Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014;383(9917):603–13. doi:10.1016/S0140-6736(13)61950-9.

    Article  PubMed  Google Scholar 

  56. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97(2):116–26. doi:97/2/116 [pii].

    Article  PubMed  Google Scholar 

  57. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med. 1997;337(14):949–55. doi:10.1056/NEJM199710023371401.

    Article  CAS  PubMed  Google Scholar 

  58. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353(9165):1641–8. doi:S0140-6736(98)09201-0 [pii].

    Article  CAS  PubMed  Google Scholar 

  59. Danish Breast Cancer Cooperative Group, Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24(15):2268–75. doi:JCO.2005.02.8738 [pii].

    Article  Google Scholar 

  60. EBCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–35. doi:10.1016/S0140-6736(14)60488-8.

    Article  Google Scholar 

  61. Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update. J Clin Oncol. 2016;34(36):4431–42. doi:10.1200/JCO.2016.69.1188.

    Article  PubMed  Google Scholar 

  62. Huang EH, Tucker SL, Strom EA, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004;22(23):4691–9. doi:22/23/4639 [pii].

    Article  PubMed  Google Scholar 

  63. Mamounas EP, Anderson SJ, Dignam JJ, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol. 2012;30(32):3960–6. doi:10.1200/JCO.2011.40.8369.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Virginia Commonwealth University Health (VCU HEALTH), Richmond, VA, USA

    Todd C. Adams MD, Nicholas Serrano MD, Christopher Chipko MD & Douglas W. Arthur MD

Authors
  1. Todd C. Adams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas Serrano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher Chipko MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Douglas W. Arthur MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd C. Adams MD .

Editor information

Editors and Affiliations

  1. Department of Pathology, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Michael Ola Idowu

  2. Department of Radiology Breast Imaging Section, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Priti Anilkumar Shah

  3. Division of Hematology Oncology and Palliative Care, Department of Internal Medicine, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Mary Helen Hackney

  4. Department of Pathology, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Margaret Mary Grimes

  5. Division of Hematology Oncology, Department of Internal Medicine, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Charles Edward Geyer, Jr.

  6. Department of Radiation Oncology, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Douglas William Arthur

  7. Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University Health (VCU HEALTH), Richmond, Virginia, USA

    Harry Douglas Bear

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Adams, T.C., Serrano, N., Chipko, C., Arthur, D.W. (2018). Overview of Radiation Oncology Evaluation and Management of Breast Tumors. In: Idowu, M., et al. Diagnosis and Management of Breast Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-57726-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-57726-5_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-57725-8

  • Online ISBN: 978-3-319-57726-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation